Managing venous thromboembolism in Asia: Winds of change in the era of new oral anticoagulants

Thrombosis Research

Volumn 130, Issue 3, 2012, Pages 291-301

  Cohen, Alexander ^a   Chiu, Kuan Ming ^b   Park, Kihyuk ^c   Jeyaindran, Sinnadurai ^d   Tambunan, Karmel L ^e   Ward, Christopher ^f   Wong, Raymond ^g   Yoon, Sung Soo ^h  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b ORIENTAL INSTITUTE OF TECHNOLOGY   (Taiwan)

^c Catholic University of Daegu   (South Korea)

^d HOSPITAL KUALA LUMPUR   (Malaysia)

^e UNIVERSITY OF INDONESIA   (Indonesia)

^f UNIVERSITY OF SYDNEY   (Australia)

^g CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^h Seoul National University   (South Korea)

Author keywords

Anticoagulant; Asia; Oral; Treatment; Venous Thromboembolism; VTE

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; RIVAROXABAN;

ANTICOAGULATION; ASIA; DEEP VEIN THROMBOSIS; EQUIPOISE; HOSPITAL PATIENT; HUMAN; LUNG EMBOLISM; OUTPATIENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; THROMBOPROPHYLAXIS; TREATMENT DURATION; VENOUS THROMBOEMBOLISM;

ADMINISTRATION, ORAL; ANTICOAGULANTS; ASIA; DRUG DESIGN; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; THROMBOEMBOLISM;

EID: 84865265185     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.05.025     Document Type: Review

References (133)

1. T. Baglin Venous thromboembolism in hospitalised patients: a public health crisis? Br J Haematol 141 2008 764 770
2. W.H. Geerts, D. Bergqvist, G.F. Pineo, J.A. Heit, C.M. Samama, and M.R. Lassen Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 Suppl. 6 2008 S381 S453
3. Z. Samuel, S.Z. Goldhaber, L. Visani, and M. De Rosa Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) Lancet 353 1999 1386 1389
4. V. Pengo, A.W.A. Lensing, M.H. Prins, A. Marchiori, B.L. Davidson, and F. Tiozzo Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism N Engl J Med 350 2004 2257 2264
5. S.R. Kahn The post-thrombotic syndrome: the forgotten morbidity of deep venous thrombosis J Thromb Thrombolysis 21 2006 41 48
6. A.T. Cohen, G. Agnelli, F.A. Anderson, J.I. Arcelus, D. Bergqvist, and J.G. Brecht VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality Thromb Haemost 98 2007 756 764
7. D.W. Barritt, and S.C. Jordan Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial Lancet 1 1960 1309 1312
8. Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial Lancet 2 1975 45 51
9. R. Collins, A. Scrimgeour, S. Yusuf, and R. Peto Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery N Engl J Med 318 1988 1162 1173
10. D.P. Brandjes, H. Heijboer, H.R. Buller, M. de Rijk, H. Jagt, and J.W. ten Cate Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis N Engl J Med 327 1992 1485 1489
11. D.W. Hommes, A. Bura, L. Mazzolai, H.R. Büller, and J.W. ten Cate Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis Ann Intern Med 116 1992 279 284
12. M.K. Gould, A.D. Dembitzer, R.L. Doyle, T.J. Hastie, and A.M. Garber Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials Ann Intern Med 130 1999 800 809
13. H. Partsch Bed rest versus ambulation in the initial treatment of patients with proximal deep vein thrombosis Curr Opin Pulm Med 8 2002 389 393
14. M.M. Koopman, P. Prandoni, F. Piovella, P.A. Ockelford, D.P. Brandjes, and J. van der Meer Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group N Engl J Med 334 1996 682 687
15. M. Rodger, C. Bredeson, P.S. Wells, J. Beck, B. Kearns, and L.B. Huebsch Cost-effectiveness of low-molecularweight heparin and unfractionated heparin in treatment of deep vein thrombosis CMAJ 159 1998 931 938
16. D.P. Brandjes, H.R. Büller, H. Heijboer, M.V. Huisman, M. de Rijk, and H. Jagt Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis Lancet 349 1997 759 762
17. P. Prandoni, A.W. Lensing, M.H. Prins, M. Frulla, A. Marchiori, and E. Bernardi Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial Ann Intern Med 141 2004 249 256
18. C. Kearon, S.R. Kahn, G. Agnelli, S. Goldhaber, G.E. Raskob, and A.J. Comerota Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 Suppl. 6 2008 S454 S545
19. C. Kearon, E.A. Akl, A.J. Comerota, P. Prandoni, H. Bounameaux, and S.Z. Goldhaber Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 Suppl. 2 2012 e419S e494S
20. V. Snow, A. Qaseem, P. Barry, E.R. Hornbake, J.E. Rodnick, and T. Tobolic Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians Ann Intern Med 146 2007 204 210
21. National Collaborating Centre for Acute and Chronic Conditions Venous thromboembolism: reducing the risk. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital National Institute for Health and Clinical Excellence (NICE) Clinical Guideline 92 2010 London (UK). Accessed 27.10.2011 at: www.nice.org.uk/nicemedia/live/ 12695/47920/47920.pdf
22. A. Torbicki, A. Perrier, S. Konstantinides, G. Agnelli, N. Galiè, and P. Pruszczyk Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Eur Heart J 29 2008 2276 2315
23. Y. Flack-Ytter, C.W. Francis, N.A. Johanson, C. Curley, O.E. Dahl, and S. Schulman Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 Suppl. 2012 e278S e352S
24. R.J. Friedman, A.S. Gallus, F.D. Cushner, G. Fitzgerald, and F.A. Anderson Jr. Global Orthopaedic Registry Investigators. Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty Curr Med Res Opin 24 2008 87 97
25. M. Monreal, A.K. Kakkar, J.A. Caprini, R. Barba, F. Uresandi, and R. Valle The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry J Thromb Haemost 2 2004 1892 1898
26. C. Kalka, D. Spirk, K.A. Siebenrock, U. Metzger, P. Tuor, and D. Sterzing Lack of extended venous thromboembolism prophylaxis in high-risk patients undergoing major orthopaedic or major cancer surgery. Electronic Assessment of VTE Prophylaxis in High-Risk Surgical Patients at Discharge from Swiss Hospitals (ESSENTIAL) Thromb Haemost 102 2009 56 61
27. A.T. Cohen, V.F. Tapson, J.F. Bergmann, S.Z. Goldhaber, A.K. Kakkar, and B. Deslandes ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study Lancet 371 2008 387 394
28. S.Z. Goldhaber Preventing pulmonary embolism and deep vein thrombosis: a 'call to action' for vascular medicine specialists J Thromb Haemost 5 2007 1607 1609
29. American Public Health Association Deep-vein thrombosis: advancing awareness to protect patient lives White paper presented at Public Health Leadership Conference on Deep-Vein Thrombosis February 26 2003 Washington, DC. Accessed on 27.10.11 at: www.apha.org/NR/rdonlyres/A209F84A-7C0E-4761-9ECF- 61D22E1E11F7/0/DVT-White-Paper.pdf
30. J. Ge, Y. Li, X. Jin, and J. Zhou Venous thromboembolism risk assessment and thromboprophylaxis among hospitalized acute medical patients in China-the RAMP study Thromb Res 126 2010 270 275
31. L.F. Tinckler Absence of pulmonary embolism in Asians? Br Med J 1 1964 502
32. W.S. Hwang The rarity of pulmonary thromboembolism in Asians Singapore Med J 9 1968 276 279
33. Cohen AT; Asia-Pacific Thrombosis Advisory Board Asia-Pacific Thrombosis Advisory Board consensus paper on prevention of venous thromboembolism after major orthopaedic surgery Thromb Haemost 104 2010 919 930
34. B. Kanchanabat, W. Stapanavatr, S. Meknavin, C. Soorapanth, C. Sumanasrethakul, and P. Kanchanasuttirak Systematic review and meta-analysis on the rate of postoperative venous thromboembolism in orthopaedic surgery in Asian patients without thromboprophylaxis Br J Surg 98 2011 1356 1364
35. B.L. Cheuk, G.C. Cheung, and S.W. Cheng Epidemiology of venous thromboembolism in a Chinese population Br J Surg 91 2004 424 428
36. A. Leizorovicz, A.G.G. Turpie, A.T. Cohen, K.S. Dhillon, P. Angchaisuksiri, and C.-J. Wang Epidemiology of post-operative venous thromboembolism in Asian countries Int J Angiol 13 2004 101 108
37. A. Leizorovicz, A.G.G. Turpie, A.T. Cohen, L. Wong, M.C. Yoo, and Dans A for the SMART Study Group Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis. The SMART Study J Thromb Haemost 3 2005 28 34
38. I.G.E. Cunningham, and N.K. Yong The incidence of postoperative deep vein thrombosis in Malaysia Br J Surg 61 1974 482 483
39. T. Chumnijarakij, and V. Poshyachinda Post-operative thrombosis in Thai women Lancet 1 1975 1357 1358
40. P. Nandi, K.P. Wong, W.I. Wei, H. Ngan, and G.B. Ong Incidence of postoperative deep vein thrombosis in Hong Kong Chinese Br J Surg 67 1980 251 253
41. K. Inada, N. Shirai, M. Hayashi, K. Matsumoto, and M. Hirose Postoperative deep venous thrombosis in Japan. Incidence and prophylaxis Am J Surg 145 1983 775 779
42. P. Phornphibulaya, P. Buranapong, B. Ruksawin, and J. Viranuvatti The incidence of post-operative DVT in Thais J Med Assoc Thai 67 1984 377 381
43. V. Atichartakarn, K. Pathepchotiwong, and C. Eurvilaichit Deep vein thrombosis after hip surgery among Thai Arch Intern Med 148 1988 1349 1353
44. P. Vathesatogkit, S. Saenghirunvattana, and P. Nitiyanant Autopsy proven cases of pulmonary embolism: 18 year study at Ramathibodi Hospital J Med Assoc Thai 72 1989 271 274
45. K.Y. Chau, S.T. Yuen, T.K. Ng, and W.F. Ng An autopsy study of pulmonary thromboembolism in Hong Kong Chinese Pathology 23 1991 181 184
46. M. Tun, I.L. Shuaib, M. Muhamad, A.H. Mat Sain, and A.S. Ressang The incidence of post-operative deep vein thrombosis in general surgical patients of Hospital Universiti Sains Malaysia Malays J Med Sci 11 2004 75 80
47. Y.H. Kim The incidence of deep vein thrombosis after cementless and cemented knee replacement J Bone Joint Surg Br 72 1990 779 783
48. K.S. Dhillon, A. Askander, and S. Doraismay Postoperative deep-vein thrombosis in Asian patients is not a rarity. A prospective study of 88 patients with no prophylaxis J Bone Joint Surg Br 78 1996 427 430
49. M.C. Yoo, Y.H. Kang, Y.H. Kim, and S.H. Kim A prospective study on the use of nadroparin calcium in the prophylaxis of thromboembolism in Korean patients undergoing total hip replacement Int Orthop 21 1997 399 402
50. Y.H. Kim, I.Y. Choi, M.R. Park, T.S. Park, and J.L. Cho Deep vein thrombosis after uncemented total hip replacement Bull Hosp Jt Dis 56 1997 133 139
51. K.H. Moon, W.H. Kim, and J.Y. Lee Deep vein thrombosis after cementless total hip replacement arthroplasty using Doppler ultrasound J Korean Orthop Assoc 33 1998 1553 1558
52. E.K. Song, J.K. Kim, K.B. Lee, and J.K. Seon Deep vein thrombosis after total knee replacement. Incidence and correlation with clinical risk factors J Korean Knee Soc 10 1998 18 22
53. S. Fujita, S. Hirota, T. Oda, Y. Kato, Y. Tsukamoto, and T. Fuji Deep venous thrombosis after total hip or total knee replacement in Japan Clin Orthop 375 2000 168 174
54. C.J. Wang, J.W. Wang, L.M. Chen, H.S. Chen, B.Y. Yang, and S.M. Cheng Deep vein thrombosis after total knee arthroplasty J Formos Assoc 99 2000 848 853
55. Y.K. Fong, P. Ruban, S.J. Yeo, B.P. Lee, N.N. Lo, and K.H. Seow Use of low molecular weight heparin for prevention of deep vein thrombosis in total knee arthroplasty. A study of its efficacy in an Asian population Ann Acad Med Singapore 29 2000 439 441
56. Y.H. Kim, and J.S. Kim Incidence and natural history of deep-vein thrombosis after total knee arthroplasty. A prospective, randomised study J Bone Joint Surg Br 84 2002 566 570
57. K.L. Tambunan, E.U. Hutagalung, L. Sukrisman, I. Saleh, S. Bambang Gunawan, and Sofyanuddin Venous thromboembolism in 13 Indonesian patients undergoing orthopaedic surgery Med J Indones 18 2009 249 256
58. N.C. Liew, K. Moissinac, and Y. Gul Postoperative venous thromboembolism in Asia: a critical appraisal of its incidence Asian J Surg 26 2003 154 158
59. F. Piovella, C.J. Wang, H. Lu, K. Lee, L.H. Lee, and W.C. Lee Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography J Thromb Haemost 3 2005 2664 2670
60. M. Sakon, Y. Maehara, H. Yoshikawa, and H. Akaza Incidence of venous thromboembolism following major abdominal surgery: a multi-center, prospective epidemiological study in Japan J Thromb Haemost 4 2006 581 586
61. S. Aniwan, and P. Rojnuckarin High incidence of symptomatic venous thromboembolism in Thai hospitalized medical patients without thromboprophylaxis Blood Coagul Fibrinolysis 21 2010 334 338
62. V. Leung, V. Leung, W. Lui, T. Chan, R.S. Wong, and G. Cheng Incidence of deep vein thrombosis in hospitalized Chinese medical patients is similar to that in western populations Thromb Res 118 2006 763 764
63. H.J. Ng, and L.H. Lee Trends in prevalence of deep venous thrombosis among hospitalized patients in an Asian institution Thromb Haemost 101 2009 1095 1099
64. L.H. Lee, K.Q. Gu, and D. Heng Deep vein thrombosis is not rare in Asia-the Singapore General Hospital experience Ann Acad Med Singapore 31 2002 761 764
65. K.K. Tan, W.P. Koh, and A.K. Chao Risk factors and presentation of deep venous thrombosis among Asian Patients: A hospital-based case-control study in Singapore Ann Vasc Surg 21 2007 490 495
66. K.K. Sun, C. Wang, X.T. Guli, and Q. Luo Risk factors and clinical features of deep venous thrombosis: a report of 388 cases Zhonghua Jie He He Hu Xi Za Zhi 27 2004 727 730
67. M. Nakamura, H. Fujioka, N. Yamada, M. Sakuma, O. Okada, and N. Nakanishi Clinical characteristics of acute pulmonary thromboembolism in Japan: results of a multicenter registry in the Japanese Society of Pulmonary Embolism Research Clin Cardiol 24 2001 132 138
68. D. Oh Current status of the Korean VTE registry Yonsei Med J 52 2011 558 561
69. P. Mutirangura, C. Rüengsethakit, and C. Wongwanit Epidemiologic analysis of proximal deep vein thrombosis in Thai patients: Malignancy, the predominant etiologic factor Int J Angio 13 2004 81 83
70. P. Angchaisuksiri, V. Atichartakarn, K. Aryurachai, N. Archararit, B. Rachakom, and K. Atamasirikul Risk factors of Thai patients with venous thromboembolism Int J Hematol 86 2007 397 402
71. Y.Y. Peng, J.S. Jeng, M.C. Shen, W. Tsay, B.S. Wang, and W.H. Lin Aetiologies and prognosis of Chinese patients with deep vein thrombosis of the lower extremities QJM 91 1998 681 686
72. H.C. Lee, W.B. Liao, M.J. Bullard, and T.S. Hsu Deep vein thrombosis in Taiwan Jpn Heart J 37 1996 891 896
73. C.H. Lee, L.J. Lin, and C.L. Cheng Kao Yang YH, Chen JY, Tsai LM. Incidence and cumulative recurrence rates of venous thromboembolism in the Taiwanese population J Thromb Haemost 8 2010 1515 1523
74. H.S. Liu, B.C. Kho, J.C. Chan, F.M. Cheung, K.Y. Lau, and F.P. Choi Venous thromboembolism in the Chinese population-experience in a regional hospital in Hong Kong Hong Kong Med J 8 2002 400 405
75. M.J. Jang, S.-M. Bang, and D. Oh Incidence of venous thromboembolism in Korea: from the Health Insurance Review and Assessment Service database J Thromb Haemost 9 2011 85 91
76. J. Fan, X. Li, Y. Cheng, C. Yao, N. Zhong, and Investigators Group Measurement of D-dimer as aid in risk evaluation of VTE in elderly patients hospitalized for acute illness: a prospective, multicenter study in China Clin Invest Med 34 2 Apr 1 2011 E96 E104
77. W.K. Ho, G.J. Hankey, and J.W. Eikelboom The incidence of venous thromboembolism: a prospective, community-based study in Perth, Western Australia Med J Aust 189 2008 144 147
78. E. Oger, and D. Mottier Incidence and risk factors for venous thromboembolism Rev Prat 6 2007 9 20
79. I.A. Naess, S.C. Christiansen, P. Romundstad, S.C. Cannegieter, F.R. Rosendaal, and J. Hammerstrom Incidence and mortality of venous thrombosis: a population-based study J Thromb Haemost 5 2007 692 699
80. M.D. Silverstein, J.A. Heit, D.N. Mohr, T.M. Petterson, W.M. O'Fallon, and L.J. Melton 3rd Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study Arch Intern Med 158 1998 585 593
81. F.A. Spencer, J.M. Gore, D. Lessard, J.D. Douketis, C. Emery, and R.J. Goldberg Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester Venous Thromboembolism Study Arch Intern Med 168 2008 425 430
82. C. Huerta, S. Johansson, M.A. Wallander, and L.A. García Rodríguez Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom Arch Intern Med 167 2007 935 943
83. R.H. White The epidemiology of venous thromboembolism Circulation 107 23 Suppl 1 2003 I4 I8
84. J.A. Heit The epidemiology of venous thromboembolism in the community Arterioscler Thromb Vasc Biol 28 2008 370 372
85. H.S. Liu, B.C. Kho, J.C. Chan, F.M. Cheung, K.Y. Lau, and F.P. Choi Venous thromboembolism in the Chinese population - experience in a regional hospital in Hong Kong Hong Kong Med J 8 2002 400 405
86. M. Sakuma, M. Nakamura, N. Yamada, S. Ota, K. Shirato, and T. Nakano Venous thromboembolism: deep vein thrombosis with pulmonary embolism, deep vein thrombosis alone, and pulmonary embolism alone Circ J 73 2009 305 309
87. J.A. Molina, Z.G. Jiang, B.H. Heng, and B.K. Ong Venous thromboembolism at the National Healthcare Group, Singapore Ann Acad Med Singapore 38 2009 470 478
88. C.H. Lee, L.J. Lin, C.L. Cheng, Y.H. Kao Yang, J.Y. Chen, and L.M. Tsai Incidence and cumulative recurrence rates of venous thromboembolism in the Taiwanese population J Thromb Haemost 8 2010 1515 1523
89. C.H. Lee, C.L. Cheng, L.J. Lin, L.M. Tsai, and Y.H. Yang Epidemiology and predictors of short-term mortality in symptomatic venous thromboembolism Circ J 75 2011 1998 2004
90. P. Angchaisuksiri Venous thromboembolism in Asia - an unrecognised and under-treated problem? Thromb Haemost 106 2011 585 590
91. N.A. Zakai, and L.A. McClure Racial differences in venous thromboembolism J Thromb Haemost 9 2011 1877 1882
92. K.S. Woo, G.Y. Mak, J.Y. Sung, J.L. Woo, C. Metreweli, and J. Vallance-Owen The incidence and clinical pattern of deep vein thrombosis in the Chinese in Hong Kong Singapore Med J 29 1988 357 359
93. Y. Yang, L. Liang, Z. Zhai, H. He, W. Xie, and X. Peng for the National Cooperative Project for the Prevention and Treatment of PTE. Pulmonary embolism incidence and fatality trends in Chinese hospitals from 1997 to 2008: a multicenter registration study PLoS One 6 2011 e26861
94. Y.S. Jeon, Y.H. Yoon, J.Y. Cho, W.K. Baek, K.H. Kim, and K.C. Hong Catheter-directed thrombolysis with conventional aspiration thrombectomy for lower extremity deep vein thrombosis Yonsei Med J 51 2010 197 201
95. L.H. Lee Clinical Update on Deep Vein Thrombosis in Singapore Ann Acad Med Singapore 31 2002 248 252
96. K.Y. Chau, S.T. Yuen, and M.P. Wong Clinicopathological pattern of pulmonary thromboembolism in Chinese autopsy patients: comparison with Caucasian series Pathology 29 1997 263 266
97. G. Lau Pulmonary embolism is not uncommon - results and implications of a five year study of 116 necropsies Ann Acad Med Singapore 24 1995 356 365
98. N. Kakkar, and R.K. Vasishta Pulmonary embolism in medical patients: an autopsy-based study Clin Appl Thromb Hemost 14 2008 159 167
99. P. Dickens, B.H. Knight, P. Ip, and W.S.Y. Fung Fatal pulmonary embolism: a comparative study of autopsy incidence in Hong Kong and Cardiff, Wales Forensic Sci Int 1997 171 174
100. Chinese Orthopaedic Association Prevention of venous thromboembolism after major orthopaedic surgery Orthop Surg 2 2010 81 85
101. R. Parakh, V.V. Kakkar, and A.K. Kakkar Management of venous thromboembolism J Assoc Physicians India 55 2007 49 70
102. S.-M. Bang, M.J. Jang, D. Oh, Y.K. Kim, I.H. Kim, and S.S. Yoon Korean Society of Thrombosis and Hemostasis. Korean guidelines for the prevention of venous thromboembolism J Korean Med Sci 25 2010 1553 1559
103. Academy of Medicine, Malaysia, Ministry of Health Malaysia, and National Heart Association of Malaysia Clinical practice guidelines: management of venous thromboembolism 2003 Accessed on 02.11.11 at: www.acadmed.org.my/view-file.cfm? fileid=278
104. N. Mashio Japanese Guidelines for Prevention of Venous Thromboembolism J Japan Soc Clin Anesth 24 2004 480 487
105. Z.F. Zairul-Nizam, and Y.A. Gul Malaysian orthopaedic surgeons' approach to venous thromboembolic disease prophylaxis: attitudes and practice J Orthop Surg (Hong Kong) 11 2003 178 183
106. L.H. Tan, and S.C. Tan Venous thromboembolism prophylaxis for surgical patients in an Asian hospital ANZ J Surg 74 2004 455 459
107. R.K. Sen, S.K. Tripathy, and A.K. Singh Is routine thromboprophylaxis justified among Indian patients sustaining major orthopedic trauma? A systematic review Indian J Orthop 45 2011 197 207
108. J.M.B. Bernardo, I. Caole, G. Pinili, and T.B. Abola Practices and attitudes of physicians on deep venous thrombosis prophylaxis among critically ill patients admitted at the medical and neurologic intensive care units Phil Heart Center J 13 2007 113 118
109. S. Prasannan, L.N. Chin, and Y.A. Gul Venous thromboembolic disease prophylaxis among general surgeons in Malaysia Asian J Surg 28 2005 125 130
110. M.S. Sheikh, and M.F. Rehman DVT prophylaxis: role of low molecular weight heparin Profess Med J 18 2011 275 279
111. T.M. Kim, J.S. Kim, S.W. Han, Y.Y.S. Hong, I. Kim, and J. Ha Clinical predictors of recurrent venous thromboembolism: a single institute experience in Korea Thromb Res 123 2009 436 443
112. J.I. Weitz New oral anticoagulants in development Thromb Haemost 103 2010 62 70
113. E. Nutescu, I. Chuatrisorn, and E. Hellenbart Drug and dietary interactions of warfarin and novel oral anticoagulants: an update J Thromb Thrombolysis 31 2011 326 343
114. Janssen Pharmaceuticals Xarelto® (rivaroxaban) tablets. Full prescribing information July 2011 Janssen Pharmaceuticals Titusville, NJ, USA Accessed on 28.11.11 at: www.xareltohcp.com/sites/default/files/pdf/xarelto-0. pdf
115. Boehringer Ingelheim Pharmaceuticals Inc Pradaxa (dabigatran etexilate mesylate) capsules for oral use. Product information August 2011 Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT, USA Accessed on 26.06.12 at: http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase= renetnt&folderPath=/Prescribing%20Information/PIs/Pradaxa/Pradaxa.pdf
116. S. Schulman, C. Kearon, A.K. Kakkar, P. Mismetti, S. Schellong, and H. Eriksson Dabigatran versus warfarin in the treatment of acute venous thromboembolism N Engl J Med 361 2009 2342 2352
117. The EINSTEIN Investigators Oral rivaroxaban for symptomatic venous thromboembolism N Engl J Med 363 2010 2499 2510
118. L. Houshan, and Y. Wang Rivaroxaban for thromboprophylaxis of venous thromboembolism after total hip or knee replacement in Chinese subjects included in the RECORD program Abstract presented at the Asia-Pacific Arthroplasty Society Meeting; Malaysia, 23-25 October 2008 2008
119. S. Schulman, D. Baanstra, H. Eriksson, S. Goldhaber, A. Kakkar, and C. Kearon Dabigatran versus placebo for extended maintenance therapy of venous thromboembolism Presented at International Society on Thrombosis and Haemostasis Congress, July 28 2011, Kyoto, Japan: Abstract O-MO-037 2011
120. EINSTEIN-PE Investigators, H.R. Büller, M.H. Prins, A.W. Lensin, H. Decousus, and B.F. Jacobson Oral rivaroxaban for the treatment of symptomatic pulmonary embolism N Engl J Med 366 2012 1287 1297
121. P. Harper, L. Young, and E. Merriman Bleeding risk with dabigatran in the frail elderly N Engl J Med 366 2012 864 866
122. S. Schulman, C. Kearon, and Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J Thromb Haemost 3 2005 692 694
123. G. Palareti Anticoagulation for venous thromboembolism. What if they bleed? Hamostaseologie 32 2012 40 44
124. C. Kearon, and J. Hirsh Current concepts: management of anticoagulation before and after elective surgery N Engl J Med 336 1997 1506 1511
125. Pradaxa® (dabigatran etexilate) Summary of Product Characteristics Accessed on 26.06.12 at: www.ema.europa.eu/docs/en-GB/document-library/EPAR- Product-Information/human/000829/WC500041059.pdf
126. Xarelto® (rivaroxaban) Summary of Product Characteristics Accessed on 22.11.11 at: www.ema.europa.eu/docs/en-GB/document-library/EPAR-Product- Information/human/000944/WC500057108.pdf
127. J. van Ryn, J. Stangier, S. Haertter, K.H. Liesenfeld, W. Wienen, and M. Feuring Dabigatran etexilate-a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity Thromb Haemost 103 2010 1116 1127
128. M. Levi, E. Eerenberg, and P.W. Kamphuisen Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents J Thromb Haemost 9 2011 1705 1712
129. E.S. Eerenberg, P.W. Kamphuisen, M.K. Sijpkens, J.C. Meijers, H.R. Buller, and M. Levi Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects Circulation 124 2011 1573 1579
130. G.J. Becker Asian leadership in chronic kidney disease J Korean Med Sci 24 Suppl. 2009 S3 S6
131. S. Schulman, R.J. Beyth, C. Kearon, M.N. Levine, and American College of Chest Physicians Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 Suppl. 6 2008 S257 S298
132. A.M. Holbrook, J.A. Pereira, R. Labiris, H. McDonald, J.D. Douketis, and M. Crowther Systematic overview of warfarin and its drug and food interactions Arch Intern Med 165 2005 1095 1106
133. D. Kubitza, M. Becka, M. Zuehlsdorf, and W. Mueck Body weight has limited influence on the safety, tolerability, pharmacokinetics, or pharmacodynamics of rivaroxaban (BAY 59-7939) in healthy subjects J Clin Pharmacol 47 2007 218 226